<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833532</url>
  </required_header>
  <id_info>
    <org_study_id>AC-Volus-01</org_study_id>
    <nct_id>NCT02833532</nct_id>
  </id_info>
  <brief_title>A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement</brief_title>
  <official_title>A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hugel</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hugel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate non-inferial study of the after using Volus
      application, compared to the powerfill.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the Penile Circumference difference at 24 weeks from Baseline value after using Volus application, compared to the Control.</measure>
    <time_frame>baseline, 24 weeks</time_frame>
    <description>Penile Circumference: The average of Distal-, Mid-, and Proximal-penis measurements when relaxed by tape measurement. Baseline value: Measured baseline length before the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Difference in Penile Circumference (each to be measured) at 4, 12 weeks (post last treatment) from Baseline value after using Volus application, compared to the Control.</measure>
    <time_frame>baseline, 4 weeks, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Difference in 5-point scale of penile appearance (each to be measured) at 4, 12, 24 weeks (post last treatment) from Baseline value after using Volus application, compared to the Control.</measure>
    <time_frame>baseline, 4 weeks, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Difference in 5-point scale of sexual satisfaction (each to be measured) at 12, 24 weeks (post last treatment)from Baseline value after using Volus application, compared to the Control.</measure>
    <time_frame>baseline, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Difference in penile length† (each to be measured) at 4, 12, 24 weeks (post last treatment) from ‡B after using Volus application, compared to the Control.</measure>
    <time_frame>baseline, 4 weeks, 12 weeks, 24 weeks</time_frame>
    <description>† penile length: A length of penile distribution measured from the ventral side of pubo-penile skin junction to the apex of prepuce when relaxed using a tape( or stick)- measure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Penile Enhancement</condition>
  <arm_group>
    <arm_group_label>Volus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maxium: 22ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Powerfill</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maxium: 22ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Volus/Powerfill</intervention_name>
    <description>Maximum: 22ml</description>
    <arm_group_label>Volus</arm_group_label>
    <arm_group_label>Powerfill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male subjects aged above 20 and below 65. (20≤male≥65)

          2. be rating himself, when screening, as &quot;Small or Very Small&quot; on Self-Questioned
             Questionnaire ( SQQ) including the question: &quot; How do you rate your penile size? //
             Very small, Small, Normal, Big, Very Big?&quot;

          3. During the study period, subjects will not received any treatments associated with
             penile enhancement.

          4. Subjects will sign an informed consent form

        Exclusion Criteria:

          1. Prior treatment for penile enhancement (e.g. fat, dermal graft).

          2. Subjects who have penile malformation (e.g. Peyronie's disease), which can make
             impossible to perform the intervention

          3. Allergic to hyalluronic acid.

          4. Inflammatory or/and infectious disease on penis that can affect on this study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HUGEL</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2016</study_first_submitted>
  <study_first_submitted_qc>July 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>August 6, 2017</last_update_submitted>
  <last_update_submitted_qc>August 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

